ALGS · Aligos Therapeutics Inc
United States · RS rating 28 · As of 2026-10-14
| Price | 5.23 USD |
|---|---|
| 1-day change | -5.1% |
| RS rating (overall / 1M / 3M / 12M) | 28 / 88 / 34 / 16 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 24 / 9 / 42 |
| Industry group (rank) | Medical-Biomed/Biotech (167) |
| EPS growth Q/Q | +37.2% |
| Sales growth Q/Q | -77.2% |
| Distance from 52-week high | +60.7% |
| Market cap (USD) | $37.9M |